FDA, Mifepristone Maker Ask For High Court Review Of Stay Upheld By 5th Circuit
WASHINGTON, D.C. — The manufacturer of the abortion drug mifepristone and the U.S. Food and Drug Administration on Sept. 8 filed separate petitions for a writ of certiorari in the U.S....To view the full article, register now.
Already a subscriber? Click here to view full article